JP2005532990A5 - - Google Patents

Download PDF

Info

Publication number
JP2005532990A5
JP2005532990A5 JP2003557494A JP2003557494A JP2005532990A5 JP 2005532990 A5 JP2005532990 A5 JP 2005532990A5 JP 2003557494 A JP2003557494 A JP 2003557494A JP 2003557494 A JP2003557494 A JP 2003557494A JP 2005532990 A5 JP2005532990 A5 JP 2005532990A5
Authority
JP
Japan
Prior art keywords
aqueous solution
nicotinamide
cyclodextrin
niacin
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003557494A
Other languages
English (en)
Japanese (ja)
Other versions
JP4611632B2 (ja
JP2005532990A (ja
Filing date
Publication date
Priority claimed from US10/033,835 external-priority patent/US6881726B2/en
Application filed filed Critical
Publication of JP2005532990A publication Critical patent/JP2005532990A/ja
Publication of JP2005532990A5 publication Critical patent/JP2005532990A5/ja
Application granted granted Critical
Publication of JP4611632B2 publication Critical patent/JP4611632B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2003557494A 2001-12-24 2002-11-07 メトロニダゾールを含む水性組成物 Expired - Lifetime JP4611632B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/033,835 US6881726B2 (en) 2001-12-24 2001-12-24 Aqueous compositions containing metronidazole
PCT/US2002/036063 WO2003057135A2 (en) 2001-12-24 2002-11-07 Aqueous compositions containing metronidazole

Publications (3)

Publication Number Publication Date
JP2005532990A JP2005532990A (ja) 2005-11-04
JP2005532990A5 true JP2005532990A5 (https=) 2006-01-05
JP4611632B2 JP4611632B2 (ja) 2011-01-12

Family

ID=21872727

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003557494A Expired - Lifetime JP4611632B2 (ja) 2001-12-24 2002-11-07 メトロニダゾールを含む水性組成物

Country Status (19)

Country Link
US (4) US6881726B2 (https=)
EP (3) EP1467744B1 (https=)
JP (1) JP4611632B2 (https=)
KR (1) KR100718858B1 (https=)
CN (1) CN100411624C (https=)
AR (1) AR037755A1 (https=)
AT (1) ATE481105T1 (https=)
AU (1) AU2002340458B2 (https=)
BR (1) BRPI0215331B8 (https=)
CA (1) CA2470492C (https=)
CY (1) CY1111095T1 (https=)
DE (1) DE60237710D1 (https=)
DK (1) DK1467744T3 (https=)
ES (1) ES2352656T3 (https=)
MX (1) MXPA04006210A (https=)
PT (1) PT1467744E (https=)
RU (2) RU2284810C2 (https=)
WO (1) WO2003057135A2 (https=)
ZA (1) ZA200405059B (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6468989B1 (en) * 2000-07-13 2002-10-22 Dow Pharmaceutical Sciences Gel compositions containing metronidazole
DE10306453A1 (de) * 2003-02-17 2004-08-26 Deutsche Telekom Ag Administrator
US7456207B2 (en) * 2003-09-25 2008-11-25 Teva Pharmaceuticals Usa, Inc. Vaginal pharmaceutical compositions and methods for preparing them
FR2866566A1 (fr) * 2004-02-20 2005-08-26 Galderma Res & Dev Utilisation d'un inhibiteur de la secretion d'il-5,il-6 et/ou il-10 pour le traitement de la rosacee
FR2887149B1 (fr) * 2005-06-17 2007-08-03 Galderma Sa Procede de solubilisation du metronidazole
US20060093675A1 (en) * 2004-10-29 2006-05-04 Mathew Ebmeier Intravaginal treatment of vaginal infections with metronidazole compositions
DE602006020063D1 (de) * 2005-12-07 2011-03-24 Univ Ramot Wirkstoffabgebende verbundkörper
ES2439582T3 (es) * 2007-03-12 2014-01-23 Dsm Ip Assets B.V. Composiciones cosméticas
US20080287514A1 (en) * 2007-05-14 2008-11-20 Jerry Zhang Topical compositions containing metronidazole
US20080287513A1 (en) * 2007-05-14 2008-11-20 Jerry Zhang Topical compositions containing metronidazole
US20080312304A1 (en) * 2007-06-13 2008-12-18 Jerry Zhang Topical compositions containing metronidazole
JP4456177B2 (ja) * 2007-09-04 2010-04-28 明治製菓株式会社 注射剤、注射液および注射用キット製剤
AR061947A1 (es) * 2008-01-08 2008-08-10 Oscar Belluscio Daniel Metodo para la obtencion del complejo gonadotrofina corionica humana (gch) / ciclodextrina administrable por via oral, producto obtenido con dicho metodo y uso clinico-terapeutico del complejo gonadotrofina corionica humana (gch) / ciclodextrina
US7893097B2 (en) 2008-02-02 2011-02-22 Dow Pharmaceutical Sciences, Inc. Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water
EP2303353B1 (en) * 2008-06-12 2018-01-10 Ramot at Tel-Aviv University Ltd. Drug-eluting medical devices
US8729108B2 (en) * 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid
US20100105750A1 (en) * 2008-10-23 2010-04-29 Nycomed Us Inc. Stable metronidazole gel formulations
EP2201930A1 (en) 2008-12-23 2010-06-30 Intendis GmbH Hydrogel composition for the treatment of dermatological disorders
EP2419138A4 (en) * 2009-04-14 2013-08-21 Medortus Uk Ltd GEL COMPOSITIONS FOR THE ADMINISTRATION OF PHARMACEUTICALLY ACTIVE COMPOUNDS
US20120171184A1 (en) 2010-12-31 2012-07-05 Lajos Szente Cellular hydration compositions
CN105903028B (zh) * 2010-12-31 2020-10-16 东塘实验室有限公司 含有环糊精的细胞水合组合物
AU2010366535A1 (en) * 2010-12-31 2013-07-11 Eastpond Laboratories Limited Cellular hydration compositions containing cyclodextrins
JP5864615B2 (ja) 2011-01-25 2016-02-17 ザ プロクター アンド ギャンブルカンパニー リポソーム及びそれを含むパーソナルケア組成物
JP5986632B2 (ja) 2011-06-28 2016-09-06 メディシス ファーマシューティカル コーポレイション 高用量粘膜接着性メトロニダゾール水系ゲル製剤および細菌性膣炎を治療するためのそれらの使用
US9511144B2 (en) 2013-03-14 2016-12-06 The Proctor & Gamble Company Cosmetic compositions and methods providing enhanced penetration of skin care actives
EP2952208A1 (en) * 2014-06-04 2015-12-09 Universidade de Santiago de Compostela Hydroalcoholic system for nail treatment
US20170232024A1 (en) 2014-08-04 2017-08-17 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
JP2015044850A (ja) * 2014-11-07 2015-03-12 イーストポンド・ラボラトリーズ・リミテッド シクロデキストリンを含有する細胞水和組成物
US9492374B2 (en) * 2015-03-25 2016-11-15 Jose Rafael Salinas Andrade Composition and method for treatment of ulcers
WO2019118928A1 (en) 2017-12-15 2019-06-20 Tarsus Pharmaceuticals, Inc. Isoxazoline parasiticide formulations and methods for treating blepharitis
US11198831B2 (en) 2019-01-31 2021-12-14 Kvi Llc Lubricant for a device
US12502377B2 (en) 2019-04-04 2025-12-23 Tarsus Pharmaceuticals, Inc. Method of eradicating ticks that attach to humans using lotilaner formulations
CN111840632A (zh) * 2019-04-25 2020-10-30 广东泰宝医疗科技股份有限公司 一种含止血微囊的液体敷料及其制备方法
EP4157290A4 (en) * 2020-06-02 2024-06-05 National University of Singapore COMPOSITIONS, THEIR USES IN THERAPY AND METHODS THEREFOR

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4032645A (en) * 1975-06-19 1977-06-28 G. D. Searle & Co. Injectable metronidazole composition
US4267169A (en) * 1978-07-22 1981-05-12 Toko Yakuhin Kogyo Kabushiki Kaisha Novel preparation of clotrimazole
GB8330969D0 (en) * 1983-11-21 1983-12-29 Wellcome Found Promoting healing
DE3346123A1 (de) 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
US4596795A (en) 1984-04-25 1986-06-24 The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
US4727064A (en) 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
US4837378A (en) 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5536743A (en) 1988-01-15 1996-07-16 Curatek Pharmaceuticals Limited Partnership Intravaginal treatment of vaginal infections with buffered metronidazole compositions
EP0335545B2 (en) 1988-03-29 1998-09-23 University Of Florida Pharmaceutical formulations for parenteral use
US5997856A (en) 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
RU2029548C1 (ru) * 1989-07-07 1995-02-27 Центр по химии лекарственных средств Антимикробное или радиосенсибилизирующее средство
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
TW200402B (https=) 1990-08-13 1993-02-21 Senju Pharma Co
DE69232535D1 (de) 1991-06-24 2002-05-08 Pacific Biomedical Res Inc In langzeitkultur gehaltene hormon-absondernde pankreatische zellen
US5747341A (en) 1991-06-24 1998-05-05 Pacific Biomedical Research, Inc. Culture media having low osmolarity for establishing and maintaining hormone-secreting cells in long-term culture
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5472954A (en) 1992-07-14 1995-12-05 Cyclops H.F. Cyclodextrin complexation
US5646131A (en) * 1994-02-22 1997-07-08 The Arab Company For Drug Industries And Medical Applicances (Acdima) Method for solubilizing drugs using cyclodextrins and carboxylic acids
ZA952521B (en) * 1994-03-28 1996-03-15 Univ Columbia Composition for inactivating irritants in fluids
FR2722098B1 (fr) 1994-07-06 1996-08-23 Cird Galderma Nouveaux medicaments a base de metro-nidazole ou d'un melange synergetique de metronidazole et de clindamycine
US5874418A (en) * 1997-05-05 1999-02-23 Cydex, Inc. Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
AU750125B2 (en) * 1997-08-27 2002-07-11 Hexal Ag New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
US6017516A (en) * 1997-10-31 2000-01-25 Lekar Pharma Limited Pharmaceutical dental formulation for topical application of metronidazole benzoate and chlorhexidine gluconate
US6183766B1 (en) 1999-02-12 2001-02-06 The Procter & Gamble Company Skin sanitizing compositions
US6468989B1 (en) * 2000-07-13 2002-10-22 Dow Pharmaceutical Sciences Gel compositions containing metronidazole
CN1116038C (zh) * 2000-11-18 2003-07-30 雷文彬 一种治疗痤疮的外用药液

Similar Documents

Publication Publication Date Title
JP2005532990A5 (https=)
JP4611632B2 (ja) メトロニダゾールを含む水性組成物
EP1283724B1 (en) Systems and methods for topical treatment with nitric oxide
JP2019131596A5 (https=)
JP2009506126A5 (https=)
JP2005509052A5 (https=)
JP2004149521A5 (https=)
JP4543679B2 (ja) 唯一の共同溶剤としてプロピレングリコールを含んでいる使用準備ができているパラセタモール注射溶液
CN105345029B (zh) 一锅法制备纳米银凝胶的方法
CN1250204C (zh) 物理稳定的可喷涂凝胶组合物
HU198839B (en) Process for producing aqueous compositions comprising hydroxy-alkadiinyl-benzoquinone derivatives as active ingredient
JPS58103312A (ja) 難溶性医薬品の注射剤用水溶液
JPS63253022A (ja) バクロフエン外用製剤
JPH11292767A (ja) 歯周炎治療用ミノサイクリン組成物
CN100591358C (zh) 高水溶性西地碘的制备方法
JP2004536810A5 (https=)
CN103860600A (zh) 用于治疗口腔溃疡的壳聚糖碘蜂蜜温敏凝胶及其制备方法
CN101015510B (zh) 一种高分子固体口含式消除口腔异味的口气清新剂的制备方法
JP4193218B2 (ja) ビオチンの溶解方法及びビオチン含有内服液剤
JPS6078581A (ja) 液状カタラ−ゼの安定法
JPH04321627A (ja) ヨウ素含有複合体の製造法並びにヨウ素含有複合体
JPH11255573A (ja) 肥料組成物
JPS61130228A (ja) ミノサイクリンを安定に配合した組成物
JPH09208465A (ja) 高濃度注射用モルヒネ液
SE0202719D0 (sv) Process for mfg crystals of growth hormone